Table 5.

Percentages of self-reported symptoms in the acute phase and 6–9 months post-infection for the two groups

	Anosognosic (n = 26)	Nosognosic (n = 76)		Anosognosic (n = 26)	Nosognosic (n = 76)
	Acute	Acute	P-value	6–9 months post	6–9 months post	P-value
Runny nose	15.4	31.6	0.110	3.8	5.3	0.773
Sore throat	19.2	17.1	0.806	0	1.3	0.557
Muscle pain	53.8	53.8	0.993	7.7	10.5	0.675
Sense of smell	26.9	53.9	0.017 **	3.8	5.3	0.773
Taste disorder	34.6	48.7	0.217	6.25	17.02	0.288
Dry cough	53.8	55.3	0.900	0	1.3	0.557
Productive cough	0	9.2	0.109	–	–	–
Fever	61.5	69.7	0.441	–	–	–
Digestive symptomsa	42.3	35.5	0.537	3.8	2.6	0.752
Fatigue	76.9	85.5	0.310	23.1	53.9	0.006 **
Difficulty breathing	42.3	44.7	0.830	0	13.2	0.051
Chest pain	19.2	27.6	0.396	0	2.6	0.403
Headache	50.0	65.8	0.153	7.7	13.2	0.455
Somnolence	15.4	32.9	0.088	3.8	9.2	0.380
Non-restorative sleep	23.1	36.8	0.199	3.8	11.8	0.237
Insomnia	15.4	9.2	0.381	0	18.4	0.018 *
Waking up feeling choked or suffocated	12.50	10.64	0.838	0	2.6	0.403
Snoring	0	1.3	0.557	0	2.6	0.403
Interruption of breathing during sleep	3.8	5.3	0.985	0	3.9	0.304
Other	23.1	21.1	0.828	7.7	27.60	0.036 *
None	11.5	1.3	0.020 **	65.4	17.1	<0.001 **

In bold all significative results before and after FDR correction.

^a Nausea/diarrhea/abdominal pain/inappetence.

^*P < 0.05.

^**P < 0.05 FDR corrected.